Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial. Stiell IG, Taljaard M, Eagles D, Yadav K, et al. BMJ 2025;391:e085632.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stiell IG, Taljaard M, Eagles D, Yadav K, et al. Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial. BMJ 2025;391:e085632.
PMID: 41218981